These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27501848)

  • 21. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis.
    Singh IM; Filby SJ; El Sakr F; Gorodeski EZ; Lincoff AM; Ellis SG; Shishehbor MH
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):257-62. PubMed ID: 20665874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population.
    Marquis-Gravel G; Matteau A; Potter BJ; Gobeil F; Noiseux N; Stevens LM; Mansour S
    Arq Bras Cardiol; 2017 Oct; 109(4):277-283. PubMed ID: 28977052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Paclitaxel-coated balloons for in-stent restenosis treatment: long-term clinical results and predictors of recurrent target lesion revascularization].
    Bossi I; D'Anna M; Vaccaro V; Caria MP; Colombo P; De Marco F; Oreglia J; Piccalò G; Piccaluga E; Soriano F; Oliva F; Klugmann S
    G Ital Cardiol (Rome); 2018 Apr; 19(4):232-238. PubMed ID: 29912237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice.
    Appleby CE; Khattar RS; Morgan K; Clarke B; Curzen N; Neyses L; Fath-Ordoubadi F
    EuroIntervention; 2011 Jan; 6(6):748-53. PubMed ID: 21205600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study.
    Alfonso F; Cuesta J; Pérez-Vizcayno MJ; García Del Blanco B; Rumoroso JR; Bosa F; Pérez de Prado A; Masotti M; Moreno R; Cequier A; Gutiérrez H; García Touchard A; López-Mínguez JR; Zueco J; Martí V; Velázquez M; Morís C; Bastante T; García-Guimaraes M; Rivero F; Fernández C;
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1841-1851. PubMed ID: 28866036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of Long-Term Outcomes After Drug-Eluting Balloon Angioplasty for Bare-Metal Stent Restenosis.
    Hsieh MJ; Huang YC; Yeh JK; Chen CC; Chen DY; Yang CH; Tsai ML; Ho MY; Chang SH; Wang CY; Lee CH; Hsieh IC
    Heart Lung Circ; 2018 May; 27(5):588-594. PubMed ID: 28625598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
    Abizaid A; Costa JR; Banning A; Bartorelli AL; Dzavik V; Ellis S; Gao R; Holmes DR; Jeong MH; Legrand V; Neumann FJ; Nyakern M; Orlick A; Spaulding C; Worthley S; Urban PM;
    JACC Cardiovasc Interv; 2012 Jan; 5(1):64-71. PubMed ID: 22230152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials).
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Sabaté M; Zueco J; Melgares R; Hernández R; Moreno R; Domínguez A; Sanchís J; Moris C; Moreu J; Cequier A; Romaguera R; Rivero F; Cuesta J; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
    Am J Cardiol; 2017 Apr; 119(7):983-990. PubMed ID: 28139220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis.
    Goel SS; Dilip Gajulapalli R; Athappan G; Philip F; Gupta S; Murat Tuzcu E; Ellis SG; Mishkel G; Kapadia SR
    Catheter Cardiovasc Interv; 2016 May; 87(6):1080-91. PubMed ID: 26613637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
    Adriaenssens T; Dens J; Ughi G; Bennett J; Dubois C; Sinnaeve P; Wiyono S; Coosemans M; Belmans A; D'hooge J; Vrolix M; Desmet W
    EuroIntervention; 2014 Aug; 10(4):439-48. PubMed ID: 25138182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis.
    Yang YX; Liu Y; Li CP; Lu PJ; Wang J; Gao J
    J Interv Cardiol; 2020; 2020():8179849. PubMed ID: 32684867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of drug-eluting balloons in the treatment of drug-eluting in-stent restenosis: experience of a tertiary care hospital.
    Dhakam S; Jafferani A; Ahmed H; Rahman N; Gowani A
    J Invasive Cardiol; 2012 Jul; 24(7):335-8. PubMed ID: 22781472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
    Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR
    J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Drug-Eluting Balloons for Patients With In-Stent Restenosis: A Meta-Analysis of 8 Randomized Controlled Trials.
    Gao S; Shen J; Mukku VK; Wang MJ; Akhtar M; Liu W
    Angiology; 2016 Aug; 67(7):612-21. PubMed ID: 26483569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
    Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
    Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-eluting balloon versus bare-mental stent and drug-eluting stent for de novo coronary artery disease: A systematic review and meta-analysis of 14 randomized controlled trials.
    Cui K; Lyu S; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang D; Dai J
    PLoS One; 2017; 12(4):e0176365. PubMed ID: 28445555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.